Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21951682 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib, Melphalan, Prednisone, Thalidomide;   Drug: Bortezomib, Melphalan, Prednisone

Indicates status has not been verified in more than two years